2.2(top 20%)
impact factor
892(top 20%)
papers
29.3K(top 10%)
citations
68(top 10%)
h-index
2.2(top 20%)
extended IF
1.0K
all documents
31.8K
doc citations
130(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of TauopathyNeurodegenerative Diseases20136,857
2Red Blood Cells Are the Major Source of Alpha-Synuclein in BloodNeurodegenerative Diseases2008414
3Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome HypothesisNeurodegenerative Diseases2013392
4Amyloid-β AggregationNeurodegenerative Diseases2007290
5Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s DiseaseNeurodegenerative Diseases2010223
6Hypermetabolism in ALS: Correlations with Clinical and Paraclinical ParametersNeurodegenerative Diseases2005208
7Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy AssessmentNeurodegenerative Diseases2012184
8Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral SclerosisNeurodegenerative Diseases2005175
9Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s DiseaseNeurodegenerative Diseases2012173
10<i>Caenorhabditis elegans</i> MPP<sup>+</sup> Model of Parkinson’s Disease for High-Throughput Drug ScreeningsNeurodegenerative Diseases2004167
11Natalizumab: Targeting α<sub>4</sub>-Integrins in Multiple SclerosisNeurodegenerative Diseases2008147
12The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and BeyondNeurodegenerative Diseases2010142
13Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer’s DiseaseNeurodegenerative Diseases2012141
14Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid AngiopathyNeurodegenerative Diseases2012140
15Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive ImpairmentNeurodegenerative Diseases2007135
16Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic MiceNeurodegenerative Diseases2008134
17Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a TargetNeurodegenerative Diseases2004133
18Assembly, Trafficking and Function of γ-SecretaseNeurodegenerative Diseases2006133
19Excitotoxicity and Amyotrophic Lateral SclerosisNeurodegenerative Diseases2005132
20Axonal Degeneration in Motor Neuron DiseaseNeurodegenerative Diseases2007132
21Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype CorrelationNeurodegenerative Diseases2010127
22Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal DementiaNeurodegenerative Diseases2008122
23Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in NeuronsNeurodegenerative Diseases2010120
24Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical StudyNeurodegenerative Diseases2018119
25Pathophysiology of Neuronal Energy Crisis in Alzheimer’s DiseaseNeurodegenerative Diseases2008116
26Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s DiseaseNeurodegenerative Diseases2010116
27Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated MeningoencephalitisNeurodegenerative Diseases2008113
28Role of p53 in Neurodegenerative DiseasesNeurodegenerative Diseases2012109
29Applications of Carbon Nanotubes in NeurobiologyNeurodegenerative Diseases2007107
30Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body DiseasesNeurodegenerative Diseases2010107
31Clinical Criteria for the Diagnosis of Parkinson’s DiseaseNeurodegenerative Diseases2010104
32Lead Exposure as a Risk Factor for Amyotrophic Lateral SclerosisNeurodegenerative Diseases200599
33A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in DementiaNeurodegenerative Diseases200797
34Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s DiseaseNeurodegenerative Diseases200893
35Default Mode Network and Extrastriate Visual Resting State Network in Patients with Parkinson’s Disease DementiaNeurodegenerative Diseases201293
36Oophorectomy, Menopause, Estrogen, and Cognitive Aging: The Timing HypothesisNeurodegenerative Diseases201091
37TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and PathophysiologyNeurodegenerative Diseases201191
38It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s DiseaseNeurodegenerative Diseases200690
39Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative DiseasesNeurodegenerative Diseases201589
40Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral SclerosisNeurodegenerative Diseases200588
41<i>S</i>-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s DiseaseNeurodegenerative Diseases201088
42Prevention of Motor Neuron Degeneration by Novel Iron Chelators in SOD1<sup>G93A</sup> Transgenic Mice of Amyotrophic Lateral SclerosisNeurodegenerative Diseases201188
43Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian StudyNeurodegenerative Diseases201288
44Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s DiseaseNeurodegenerative Diseases200887
45Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from SwedenNeurodegenerative Diseases201286
46Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an EyewitnessNeurodegenerative Diseases200885
47Plasma Urate and Progression of Mild Cognitive ImpairmentNeurodegenerative Diseases200985
48Impaired Performance of Female APP/PS1 Mice in the Morris Water Maze Is Coupled with Increased Aβ Accumulation and Microglial ActivationNeurodegenerative Diseases201385
49MRI for Iron Mapping in Alzheimer's DiseaseNeurodegenerative Diseases201484
50The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related DementiaNeurodegenerative Diseases201483